ATE264868T1 - Asialoglykoproteine des hepatitis c virus - Google Patents
Asialoglykoproteine des hepatitis c virusInfo
- Publication number
- ATE264868T1 ATE264868T1 AT97120661T AT97120661T ATE264868T1 AT E264868 T1 ATE264868 T1 AT E264868T1 AT 97120661 T AT97120661 T AT 97120661T AT 97120661 T AT97120661 T AT 97120661T AT E264868 T1 ATE264868 T1 AT E264868T1
- Authority
- AT
- Austria
- Prior art keywords
- hcv
- mannose
- binding protein
- ags
- compsn
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title abstract 13
- 108010002913 Asialoglycoproteins Proteins 0.000 title 1
- 102000009112 Mannose-Binding Lectin Human genes 0.000 abstract 5
- 108010087870 Mannose-Binding Lectin Proteins 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 3
- 108010062580 Concanavalin A Proteins 0.000 abstract 2
- 230000001105 regulatory effect Effects 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 101710186708 Agglutinin Proteins 0.000 abstract 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 1
- 241000234271 Galanthus Species 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 101710146024 Horcolin Proteins 0.000 abstract 1
- 101710189395 Lectin Proteins 0.000 abstract 1
- 101710179758 Mannose-specific lectin Proteins 0.000 abstract 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 abstract 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 abstract 1
- 102000007365 Sialoglycoproteins Human genes 0.000 abstract 1
- 108010032838 Sialoglycoproteins Proteins 0.000 abstract 1
- 239000000910 agglutinin Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003149 assay kit Methods 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61141990A | 1990-11-08 | 1990-11-08 | |
US75888091A | 1991-09-13 | 1991-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE264868T1 true ATE264868T1 (de) | 2004-05-15 |
Family
ID=27086508
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97120661T ATE264868T1 (de) | 1990-11-08 | 1991-11-07 | Asialoglykoproteine des hepatitis c virus |
AT04076119T ATE414102T1 (de) | 1990-11-08 | 1991-11-07 | Asialoglykoproteine von hepatitis c virus |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04076119T ATE414102T1 (de) | 1990-11-08 | 1991-11-07 | Asialoglykoproteine von hepatitis c virus |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1471073B1 (de) |
AT (2) | ATE264868T1 (de) |
DE (2) | DE69133609D1 (de) |
DK (1) | DK1471073T3 (de) |
ES (2) | ES2218629T5 (de) |
IE (1) | IE913916A1 (de) |
PL (1) | PL175610B1 (de) |
RO (1) | RO117920B1 (de) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0185373B1 (ko) * | 1989-03-17 | 1999-05-01 | 로버트 피. 블랙버언 | Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용 |
-
1991
- 1991-11-07 DE DE69133609T patent/DE69133609D1/de not_active Expired - Lifetime
- 1991-11-07 DK DK04076119T patent/DK1471073T3/da active
- 1991-11-07 ES ES97120661T patent/ES2218629T5/es not_active Expired - Lifetime
- 1991-11-07 DE DE69133382T patent/DE69133382T3/de not_active Expired - Lifetime
- 1991-11-07 PL PL91300038A patent/PL175610B1/pl unknown
- 1991-11-07 RO RO97-01809A patent/RO117920B1/ro unknown
- 1991-11-07 AT AT97120661T patent/ATE264868T1/de not_active IP Right Cessation
- 1991-11-07 EP EP04076119A patent/EP1471073B1/de not_active Expired - Lifetime
- 1991-11-07 AT AT04076119T patent/ATE414102T1/de not_active IP Right Cessation
- 1991-11-07 ES ES04076119T patent/ES2314334T3/es not_active Expired - Lifetime
- 1991-11-08 IE IE391691A patent/IE913916A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2314334T3 (es) | 2009-03-16 |
IE913916A1 (en) | 1992-05-20 |
IE970761A1 (en) | 2000-02-23 |
DE69133382T2 (de) | 2005-05-04 |
DE69133382T3 (de) | 2009-10-08 |
ATE414102T1 (de) | 2008-11-15 |
DE69133609D1 (de) | 2008-12-24 |
PL175610B1 (pl) | 1999-01-29 |
DE69133382D1 (de) | 2004-06-03 |
DK1471073T3 (da) | 2009-01-26 |
ES2218629T3 (es) | 2004-11-16 |
EP1471073B1 (de) | 2008-11-12 |
EP1471073A3 (de) | 2004-12-01 |
ES2218629T5 (es) | 2009-06-02 |
RO117920B1 (ro) | 2002-09-30 |
EP1471073A2 (de) | 2004-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nishi et al. | Purification of human, dog and rabbit α-fetoprotein by immunoadsorbents of Sepharose coupled with anti-human α-fetoprotein | |
Hiremath et al. | Immunological detection of the messenger RNA cap-binding protein. | |
FI20021626A (fi) | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi | |
ES8100502A1 (es) | Un procedimiento para purificar proteinas con pesos moleculares superiores a 12.000,en particular interferon | |
DK1084136T3 (da) | Adskillelse af monomere af et antistof fra dets multimere ved anvendelse af ionbytterchromatografi | |
BR9809443A (pt) | Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão. | |
Thorpe et al. | Studies on papain produced subunits of human γG-globulins—II: Structures of peptides related to the genetic Gm activity of γG-globulin Fc-fragments | |
EP0696640A3 (de) | Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus | |
KR870700073A (ko) | 임파선증 관련 바이러스(lav)의 게놈성 rna에 의해 암호된 프로테인에 대한 단일클론 항체와 이러한 항체를 분비하는 하이브리도마 | |
FR2677767B1 (fr) | Procede de detection de l'infection par le virus de la diarrhee bovine, sequence nucleotidique codant pour une proteine induite par l'infection par ce virus et proteines et antigenes recombinants s'y rapportant . | |
US4908432A (en) | Novel polypeptide having gamma-interferon activity | |
ATE264868T1 (de) | Asialoglykoproteine des hepatitis c virus | |
MY116208A (en) | Improved hcv diagnostic agents | |
ES2170195T3 (es) | Peptidos del virus de epstein-barr y anticuerpos contra estos peptidos. | |
James et al. | The effect of α2 macroglobulin in commercial cytokine assays | |
Philipson et al. | Interaction between poliovirus and immunoglobulins: I. Detection of virus antibodies by partition in aqueous polymer phase systems | |
Proost et al. | Posttranslational processing of chemokines | |
Tallet et al. | One-step chromatographic purification procedure of a His-tag recombinant carboxyl half part of the HTLV-I surface envelope glycoprotein overexpressed in Escherichia coli as a secreted form | |
Ball et al. | Lentivirus antigen purification and characterization: isolation of equine infectious anemia virus gag and env proteins in one step by reverse phase HPLC and application to human immunodeficiency virus glycoproteins | |
Pestka et al. | Monoclonal antibodies can discriminate between some active and inactive forms of leukocyte interferon | |
EP1321476B1 (de) | Verbindendes Protein | |
FI942184A0 (fi) | Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita | |
Fassina | Protein A Mimetic (PAM) Affinity Chromatography: Immunoglobulins Purification | |
Schröder et al. | Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet-factor 4 | |
Meurs et al. | Purification of human leukocyte interferon to homogeneity with the use of a monoclonal antibody: detailed technique and parameters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0842947 Country of ref document: EP |
|
UEP | Publication of translation of european patent specification |
Ref document number: 0842947 Country of ref document: EP |
|
EELA | Cancelled due to lapse of time |